(NEO:Consolidated Issue listed on NASDAQ Capital Market)
Maher Albitar M.D.
Chief Medical Officer and Director of Research & Development, Neogenomics Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 4 different industries.|
As of Fiscal Year 2012
Dr. Maher Albitar, M.D. has been Chief Medical Officer and Director of Research & Development at NeoGenomics Laboratories, Inc. since January 2012. Dr. Albitar has been Chief Medical Officer and Director of Research & Development of Neogenomics Inc. since January 9, 2012. Dr. Albitar served as a Consultant of Health Discovery Corporation since November 15, 2012 and served as its Chief Medical Officer from May 2010 to April 7, 2011. Dr. Albitar has also served as a consultant ...
12701 Common Wealth DrivePhone: 239-768-0600
Fort Myers, Florida 33913
Board Members Memberships*
Damascus Medical School In Damascus Syria
The University of Pennsylvania
|Peter D. Meldrum Ph.D.||Chief Executive Officer, President and Director|
Myriad Genetics Inc.
|Marc D. Grodman M.D.||Founder, Chairman, Chief Executive Officer, President and Managing Director|
Bio-Reference Laboratories Inc.
|Kimberly J. Popovits||Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee|
Genomic Health Inc.
|Thomas A. Bologna||Chairman and Chief Executive Officer|
Response Genetics, Inc
|Michael J. Pellini M.D., MBA||Chief Executive Officer, President and Director|
Foundation Medicine, Inc.
|$395.0K||Compensation as of Fiscal Year 2013.|
Post a JobJobs
- Pittsburgh, PA | Carnegie Museums of PittsburghPosted: Dec 09
- New York, NY | JPMorgan ChasePosted: Dec 06
- Alexandria, VA |Posted: Dec 06
- Detroit, MI | Wayne State UniversityPosted: Nov 26